Polarean Imaging Ltd (POLX) ORD GBP0.00037
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
n/a
n/a
8.00p
£15.69 million
1.30p
n/a
1.18p
n/a
0.03p (1.96%) Previous:
0.03p
n/a
n/a
200,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue ($m) | 0.89 | 1.03 |
| Profit before tax ($m) | (11.88) | (13.91) |
| Adjusted EPS (¢): | (4.69) | (5.63) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Polarean's Xenoview 3T gets new FDA clearance
21 November 2024 15:51
-
Polarean appoints Xenon MRI specialist as chief medical advisor
28 August 2024 12:03
-
Polarean Imaging retains co-founder on consultant basis
15 August 2024 12:19
-
Holding(s) in Company
11 December 2024 14:52
-
FDA clears Chest Coil in GE HealthCare MRI Systems
21 November 2024 07:00
-
Virtual investor day
25 September 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.